BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 30617087)

  • 21. Lichenoid drug eruption on the lower lip caused by anti-PD-1 monoclonal antibody: a case report and literature review.
    Kan S; Ren H; Gao Z; Dai E; Liu Y; Yang L; Cai Q
    Immunotherapy; 2021 Dec; 13(17):1373-1378. PubMed ID: 34632814
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Annular lichenoid dermatitis of youth.
    Annessi G; Paradisi M; Angelo C; Perez M; Puddu P; Girolomoni G
    J Am Acad Dermatol; 2003 Dec; 49(6):1029-36. PubMed ID: 14639381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Giant cell lichenoid dermatitis within herpes zoster scars in a bone marrow recipient.
    Córdoba S; Fraga J; Bartolomé B; García-Díez A; Fernández-Herrera J
    J Cutan Pathol; 2000 May; 27(5):255-7. PubMed ID: 10847551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lichenoid papular eruption in a child. Frictional lichenoid dermatitis of childhood (FLDC).
    Serna MJ; España A; Idoate MA; Quintanilla E
    Arch Dermatol; 1994 Jan; 130(1):106-7, 109-10. PubMed ID: 8285727
    [No Abstract]   [Full Text] [Related]  

  • 25. Adalimumab-induced lichenoid drug eruption.
    El Habr C; Meguerian Z; Sammour R
    J Med Liban; 2014; 62(4):238-40. PubMed ID: 25807724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Eruptive Keratoacanthomas Associated With Pembrolizumab Therapy.
    Freites-Martinez A; Kwong BY; Rieger KE; Coit DG; Colevas AD; Lacouture ME
    JAMA Dermatol; 2017 Jul; 153(7):694-697. PubMed ID: 28467522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Debilitating erosive lichenoid interface dermatitis from checkpoint inhibitor therapy.
    Davis MJ; Wilken R; Fung MA; Tartar DM
    Dermatol Online J; 2018 Apr; 24(4):. PubMed ID: 29906009
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Keratosis lichenoides chronica: marked response to calcipotriol ointment.
    Chang SE; Jung EC; Hong SM; Choi JH; Sung KJ; Moon KC; Koh JK
    J Dermatol; 2000 Feb; 27(2):123-6. PubMed ID: 10721662
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful Outpatient Management of Diffuse Photosensitive Bullous Dermatitis Following Pembrolizumab Therapy.
    Penny C; Nath N; Kheterpal M
    J Drugs Dermatol; 2022 Jun; 21(6):668-670. PubMed ID: 35674751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Annular lichenoid dermatitis of youth in a 15-year-old boy: Topical tacrolimus as a treatment option.
    Ülkümen PK; Kocatürk E; Güngör Ş; Erzurumluoğlu N
    Indian J Dermatol Venereol Leprol; 2016; 82(4):467. PubMed ID: 27279324
    [No Abstract]   [Full Text] [Related]  

  • 31. Annular lichenoid dermatitis of youth: a separate entity or on the spectrum of mycosis fungoides? Case report and review of the literature.
    Kazlouskaya V; Trager JD; Junkins-Hopkins JM
    J Cutan Pathol; 2015 Jun; 42(6):420-6. PubMed ID: 25732922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mycosis Fungoides Manifesting as Giant Cell Lichenoid Dermatitis.
    Belousova IE; Khairutdinov VR; Bessalova A; Kazakov DV
    Am J Dermatopathol; 2018 Apr; 40(4):283-285. PubMed ID: 29135510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Giant cell lichenoid dermatitis: a possible manifestation of sarcoidosis.
    Goldberg LJ; Goldberg N; Abrahams I; Silvers DN; Szaniawski W; Halperin AJ
    J Cutan Pathol; 1994 Feb; 21(1):47-51. PubMed ID: 8188933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bilateral Lower Extremity Skin Eruptions in an HIV-Positive Man Receiving Pembrolizumab Monotherapy for Non-Small Cell Lung Cancer.
    Boozalis E; Kwatra SG; Marrone KA
    JAMA Oncol; 2019 Feb; 5(2):261-262. PubMed ID: 30286225
    [No Abstract]   [Full Text] [Related]  

  • 35. Dermatologic Reactions to Immune Checkpoint Inhibitors : Skin Toxicities and Immunotherapy.
    Sibaud V
    Am J Clin Dermatol; 2018 Jun; 19(3):345-361. PubMed ID: 29256113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cycloserine-induced lichenoid drug eruption.
    Shim JH; Kim TY; Kim HO; Kim CW
    Dermatology; 1995; 191(2):142-4. PubMed ID: 8520062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravenous immunoglobulin-induced lichenoid dermatitis: a unique adverse reaction.
    Yockey SM; Ahmed I
    Mayo Clin Proc; 1997 Dec; 72(12):1151-2. PubMed ID: 9413297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Itch in Atopic Dermatitis Management.
    Kamata Y; Tominaga M; Takamori K
    Curr Probl Dermatol; 2016; 50():86-93. PubMed ID: 27578076
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histologic Assessment of Lichenoid Dermatitis Observed in Patients With Advanced Malignancies on Antiprogramed Cell Death-1 (anti-PD-1) Therapy With or Without Ipilimumab.
    Chou S; Hwang SJ; Carlos G; Wakade D; Fernandez-Penas P
    Am J Dermatopathol; 2017 Jan; 39(1):23-27. PubMed ID: 28045749
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lichenoid and subacute cutaneous lupus erythematosus-like dermatitis associated with antihistamine therapy.
    Crowson AN; Magro CM
    J Cutan Pathol; 1999 Feb; 26(2):95-9. PubMed ID: 10082400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.